Delivery Order SPE2DB20D3103-SPE2DB24FN2E9
- Not listed
- This federal contract award, valued at $1,162.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of March 28, 2025. The contract covers the delivery of 4567720782 units of Oxycodone HCL (IR) 5 mg tablets, a critical pain management medication, to support federal healthcare programs....
- This federal contract award, valued at $1,448.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,115,975 units of Oxycodone HCl (IR) 5 mg tablets, a pain management medication, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract is a Delivery Order with a Firm Fixed Price pricing type and has...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,471.18 firm-fixed-price delivery order is for the supply of 4,567,460,541 units of 5 mg oxycodone HCL immediate-release tablets. The contract has an ultimate completion date of March 5, 2025 and was awarded on March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of 4,566,768,044 units of oxycodone hydrochloride 5 mg tablets. The $1,617.80 firm fixed price contract was awarded on December 19, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 20, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,924,090 tablets of 5 mg oxycodone hydrochloride, an immediate-release pain medication. The contract has a firm fixed price of $1,359.64 and a performance period ending on April 16, 2025. This order is not associated with a set-aside program and is an open competition award. AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.76 delivery order contract covers the supply of 4,566,456,182 tablets of 5 mg Oxycodone HCL, an immediate-release opioid pain medication. The contract has a completion date of November 18, 2024 and uses a firm fixed-price pricing type. This award is not associated with a set-aside program. Amerisourcebergen...
- This federal contract award, valued at $1,729.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award, with ID SPE2DB22D2206|SPE2DB25FGR00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of 4,567,968,350 units of Oxycodone HCL (IR) 5 mg tablets in 100-count bottles. The contract has a ceiling value of $1,354.26 and an ultimate completion date of April 21, 2025. The...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,479.68 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of 4,564,766,219 units of the prescription drug Oxycodone HCl 5mg tablet. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Oxycodone HCL 5 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $3,605.83 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN2E9Delivery Order
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $1,347.18. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,564,167,843 units of Oxycodone HCl (IR) 5 mg tablets. The contract has an ultimate completion date of March 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/28/24 |